The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and ...

At the 2026 NCCN Annual Meeting, CURE sat down with Dr. Thomas Flaig to discuss the rapidly evolving landscape of bladder ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire ...

The U.S. Food and Drug Administration (FDA) on Wednesday delayed its decision on Sanofi SA’s SNY subcutaneous Sarclisa ...

The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.

Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

Doctors say about 1 in 5 patients receiving immune checkpoint inhibitors develop acute kidney injury during treatment.

A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically reprogramming their gene activity. Credit: Shutterstock Cancer cells may “learn ...

Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy ...

A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...

The free lodging, meals, and support Duane received as a guest at Hope Lodge Baltimore made it possible for him to take part ...